HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

Abstract
We examined the treatment effects of two structurally distinct phosphodiesterase type IV (PDE IV) inhibitors, BBB022 and rolipram, in murine and rat models of experimental autoimmune encephalomyelitis (EAE). Based on our data, we propose a mechanism of action which may supplement immunomodulatory effects of PDE IV inhibitors. In particular, PDE inhibitors promote elevation of intracellular cAMP levels, increasing the electrical resistance of endothelial monolayers by stabilizing intercellular junctional complexes. Such an effect on central nervous system (CNS) vascular endothelium has the potential to reduce disease severity in EAE, because both inflammatory cells and humoral factors readily cross a disrupted blood-brain barrier (BBB). In this report, we demonstrate the capacity of BBB022 and rolipram to decrease clinical severity of EAE. further, PDE IV inhibitors significantly reduced BBB permeability in the spinal cords of mice with EAE. These results provide evidence that PDE IV-inhibitors may exert therapeutic effects in EAE by modifying cerebrovascular endothelial permeability, reducing tissue edema as well as entry of inflammatory cells and factors.
AuthorsV A Folcik, T Smith, S O'Bryant, J A Kawczak, B Zhu, H Sakurai, A Kajiwara, J M Staddon, A Glabinski, A L Chernosky, M Tani, J M Johnson, V K Tuohy, L L Rubin, R M Ransohoff
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 97 Issue 1-2 Pg. 119-28 (Jun 1 1999) ISSN: 0165-5728 [Print] NETHERLANDS
PMID10408965 (Publication Type: Journal Article)
Chemical References
  • BBB022A
  • Organic Chemicals
  • Phosphodiesterase Inhibitors
  • Pyrrolidinones
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Rolipram
Topics
  • 3',5'-Cyclic-AMP Phosphodiesterases (antagonists & inhibitors)
  • Acute Disease
  • Animals
  • Blood-Brain Barrier (drug effects, immunology)
  • Brain Edema (drug therapy, immunology)
  • Central Nervous System (enzymology, immunology)
  • Chronic Disease
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Encephalomyelitis, Autoimmune, Experimental (drug therapy, immunology)
  • Female
  • Mice
  • Mice, Inbred Strains
  • Organic Chemicals
  • Phosphodiesterase Inhibitors (pharmacology)
  • Pyrrolidinones (pharmacology)
  • Rats
  • Rats, Inbred Lew
  • Recurrence
  • Rolipram

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: